Mirae Asset Global Investments Co., Ltd. Castle Biosciences Inc Transaction History
Mirae Asset Global Investments Co., Ltd.
- $30.9 Billion
- Q3 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Castle Biosciences Inc stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 1,121 shares of CSTL stock, worth $37,497. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,121
Previous 1,115
0.54%
Holding current value
$37,497
Previous $22,000
13.64%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding CSTL
# of Institutions
185Shares Held
27MCall Options Held
42.2KPut Options Held
9.3K-
Black Rock Inc. New York, NY3.04MShares$102 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.17MShares$72.7 Million0.0% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.79MShares$60 Million0.02% of portfolio
-
Portolan Capital Management, LLC Boston, MA1.52MShares$50.7 Million2.16% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.47MShares$49.3 Million0.01% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $880M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...